Log In
Print
BCIQ
Print
Print this Print this
 

APD515

  Manage Alerts
Collapse Summary General Information
Company Acacia Pharma Ltd.
DescriptionOromucosal formulation of an undisclosed marketed muscarinic agonist
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationXerostomia
Indication DetailsTreat xerostomia (dry mouth) in advanced cancer patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today